Navigation Links
High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy
Date:7/5/2011

High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).

"The new analysis of the Phase III FLEX study has allowed us to identify which non-small cell lung cancer patients are most likely to benefit from treatment with Erbitux in the first-line setting," said principal investigator Dr. Robert Pirker of the Medical University of Vienna in Austria. "By demonstrating that high EGFR expression is the first predictive biomarker for improved overall survival in advanced NSCLC, we have taken a major step towards a more personalized approach in this difficult-to-treat disease."

Based on a new analysis of all FLEX patients (1,121 out of 1,125 FLEX study patients), researchers found that patients with high tumor EGFR expression (200 and above on a scale of 0-300) consistently benefited from the addition of cetuximab to chemotherapy regardless of histology. Within this group, overall survival averaged 12 months, compared with 9.6 months for patients receiving chemotherapy alone.

In patients with low EGFR expression, no difference in overall survival was seen between patients receiving chemotherapy plus cetuximab, compared to those receiving chemotherapy alone.


'/>"/>

Contact: Renee McGaw
renee.mcgaw@ucdenver.edu
31-205-493-413
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1

Related medicine news :

1. Gene expression changes in nasal cells may help identify lung cancer in earliest stages
2. Smokers undergo the same changes in gene expression as patients with COPD
3. Gene expression predicts chemotherapy sensitivity of triple-negative breast cancer
4. RxPONDER trial will evaluate whether gene expression test can drive chemotherapy choice
5. Low doses of penta-brominated diphenyl ether flame retardants alter gene expression
6. Novel mechanism for control of gene expression revealed
7. New study finds molecular mechanisms that control Rb2/p130 gene expression in lung cancer
8. Gene expression to distinguish metastasizing from non-metastasizing head and neck cancers
9. Oncometabolite linked with widespread alterations in gene expression
10. Overexpression of repetitive DNA sequences discovered in common tumor cells
11. Attention ladies and gentlemen: Courtship affects gene expression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... ... For over 23 years, Doctors on Liens has committed to ... and therapists treating personal injury patients on a lien basis. With the recent addition ... in Santa Monica, Doctors on Liens is continuing that tradition. While the network ...
(Date:5/3/2016)... MA (PRWEB) , ... May 03, 2016 , ... Registration is now open for the ... June 5, 2016 at the Hatch Memorial Shell on the Esplanade. The event regularly draws ... The 5K Run is a competitive, timed event fully sanctioned by the USA Track & ...
(Date:5/3/2016)... ... , ... Cosmetic surgeon Dr. Mark Youssef first introduced Voluma® to his ... his menu of services to give his patients as many options as possible in ... improving his approach to ensure he stays at the forefront of the most modern ...
(Date:5/3/2016)... Pasadena, CA (PRWEB) , ... May 03, 2016 ... ... tuition-free, accredited American online university, has announced today the launch of its Associates ... Nobel Laureate and President Emeritus of The Rockefeller University, Dr. Torsten N. Wiesel; ...
(Date:5/3/2016)... ... May 03, 2016 , ... Nationally recognized personal injury law firm Monge & Associates ... roses to anyone who wants one for their Mother or any other mother figure. , ... contributions of Mothers.” Monge goes on to say, “we are choosing to do this ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... announced today that it is celebrating Hepatitis Awareness Month with a campaign to honor patients ... and encourage those at risk to get tested and begin the road to a life ... ... ... Inc.) ...
(Date:5/3/2016)... PROVO, Utah , May 3, 2016  Forté Elements, LLC (Forté) is excited ... use nutritional products that address the nutritional needs of recovery for a variety of ... its products. Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)... , May 2, 2016  Deerfield announced today ... of Graybug Vision, Inc. Graybug Vision is an ... that may transform care for ocular diseases including ... Vision,s technology was first developed at Johns Hopkins ... startup venture. Graybug Vision is ...
Breaking Medicine Technology: